A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants

Exclusion Criteria

• •Clinically relevant evidence or history of illness or disease
• •Pregnant or nursing females
• •History of febrile illness within 7 days prior to the first dose of study drug or subjects with evidence of active infection
• •Any condition possibly affecting drug absorption (e.g., gastrectomy, cholecystectomy)
• •Positive for HIV or hepatitis
• •Positive urine drug screen
• •Current tobacco smokers or use of tobacco within 3 months prior to Screening.
• •Received any vaccine, an investigational agent, or biological product within 28 days or 5 times the t½ of receipt of study drug, whichever is longer.
• •Drug sensitivity to midazolam, caffeine, rosuvastatin